Respiratory System – LiveSpo Navax
Contains 5 billion spores of the beneficial bacteria Bacillus Clausii and Bacillus subtilis in each tube
Indications
Associated publications
Tran DM, Tran TT, Phung TTB, Bui HT, Nguyen PTT, Vu TT, et al. Nasal-spraying Bacillus spores as an effective symptomatic treatment for children with acute respiratory syncytial virus infection. Sci Rep. 2022;12(1): 12402. doi: 10.1038/s41598-022-16136-z.
Trần Thanh Tú, Nguyễn Thị Vân Anh, Phùng Thị Bích Thủy, Bùi Thị Huyền, Nguyễn Thị Thanh Phúc, Vũ Thị Tâm và cộng sự. LiveSpo® Navax chứa bào tử lợi khuẩn Bacillus shỗ trợ hiệu quả điều trị triệu chứng và giảm nồng độ virus hợp bào hô hấp (RSV) ở trẻ em. Tạp chí Nhi khoa. 2021;14(2): 35-43.
Tran TT, Nguyen ATV, Phung TTB, Bui HT, Nguyen PTT, Ngo NTP, et al. LiveSpo® Navax probiotics contain Bacillus spores effectively support symptomatic treatment and reduce the concentration of respiratory syncytial virus (RSV) in children. Journal of Pediatrics. 2021;14(2): 35-43
Phùng Thị Bích Thủy, Trần Thanh Tú, Bùi Thị Huyền, Nguyễn Thị Thanh Phúc, Vũ Thị Tâm và cộng sự. Bước đầu đánh giá hiệu quả giảm triệu chứng và nồng độ vi rút cúm ở trẻ em viêm đường hô hấp khi sử dụng sản phẩm LiveSpo® Navax dạng xịt chứa bào tử lợi khuẩn Bacillus. Tạp chí Y học Dự phòng. 2022;32(3): 48-59. DOI: https://doi.org/10.51403/0868-2836/2022/638.
Phung TTB, Tran TT, Bui HT, Nguyen PTT, Vu TT, Ngo NTP, et al. Effective symptomatic treatment and reduction of influenza viral load in children by using nasal-spraying Bacillus probiotic spores (LiveSpo® Navax). Vietnam Jour of Pre Med. 2022;32(3): 48-59. doi: 10.51403/0868-2836/2022/638
Khodavirdipour A, Chamanrokh P, Alikhani MY, Alikhani MS. Potential of Bacillus subtilis against SARS-CoV-2 – A sustainable drug development perspective. Front Microbiol. 2022;13: 718786. doi: 10.3389/fmicb.2022.718786.
Lefevre M, Racedo SM, Ripert G, Housez B, Cazaubiel M, Maudet C, et al. Probiotic strain Bacillus subtilis CU1 stimulates immune system of elderly during common infectious disease period: a randomized, double-blind placebo-controlled study. Immun Ageing. 2015;12: 24. doi: 10.1186/s12979-015-0051-y.
Lehtoranta L, Pitkäranta A, Korpela R. Probiotics in respiratory virus infections. Eur J Clin Microbiol Infect Dis. 2014;33(8): 1289-302. doi: 10.1007/s10096-014-2086-y.
Song M, Hong HA, Huang JM, Colenutt C, Khang DD, Nguyen TV, et al. Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine. Vaccine. 2012;30(22): 3266-77. doi: 10.1016/j.vaccine.2012.03.016.
Marseglia GL, Tosca, M., Cirillo, I., Licari, A., Leone, M., Marseglia, A., & Ciprandi, G. Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot study. Ther Clin Risk Manag. 2007;3(1): 13. doi: doi:10.2147/tcrm.2007.3.1.13.
Slivnik M, Črnigoj Kristan, K., Čebron Lipovec, N., Locatelli, I., Orel, R., & Winger, A. M. Effect of daily Bacillus subtilis DE111® intake on gastrointestinal health and respiratory infections in children attending day-care: A randomised, parallel, double-blind, placebo-controlled study. J Probiotics Heal. 2020;8: 1-7